JSPR - Jasper Therapeutics, Inc.

QQQ $ 608.59 $ -9.26 (-1.5 %)

DIA $ 475.50 $ -6.59 (-1.37 %)

SPY $ 672.57 $ -8.41 (-1.24 %)

TLT $ 89.38 $ -0.42 (-0.46 %)

GLD $ 384.40 $ -4.31 (-1.11 %)

Previous Close

$ 1.61

Open

$ 1.77

Bid

$ 1.55 x 30

Ask

$ 1.85 x 570

Day's Range

$ 1.56 - $ 1.77

52 Week Range

$ 1.56 - $ 26.05

Volume

480,126

Average Volume

Market Cap

26.78M

Beta (5Y Monthly)

$ 2.33

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-10-2025	09-30-2025	10-Q
2	08-13-2025	06-30-2025	10-Q
3	05-12-2025	03-31-2025	10-Q
4	02-28-2025	01-01-1970	10-K
5	11-07-2024	09-30-2024	10-Q
6	08-13-2024	06-30-2024	10-Q
7	05-14-2024	03-31-2024	10-Q
8	03-05-2024	12-31-2023	10-K
9	11-09-2023	09-30-2023	10-Q
10	08-11-2023	06-30-2023	10-Q
11	05-12-2023	03-31-2023	10-Q
12	03-08-2023	12-31-2022	10-K
13	11-10-2022	09-30-2022	10-Q
14	08-12-2022	06-30-2022	10-Q
15	05-12-2022	03-31-2022	10-Q
16	03-18-2022	12-31-2021	10-K
17	11-12-2021	09-30-2021	10-Q
18	08-16-2021	06-30-2021	10-Q
19	05-24-2021	03-31-2021	10-Q
20	03-30-2021	12-31-2020	10-K
21	11-10-2020	09-30-2020	10-Q
22	08-14-2020	06-30-2020	10-Q
23	05-13-2020	03-31-2020	10-Q
24	03-26-2020	12-31-2019	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

RBC Capital Maintains Sector Perform on Ja...
11/11/2025 15:25:08

RBC Capital analyst Leonid Timashev maintains Jasper Therapeutics (NASDAQ:JSPR) with a Sector Perform and lowers the price t...

coreweave-bulls-should-brace-for-wild-lumpy-volatile-ride-jpmorgan-says

CoreWeave Bulls Should Brace For 'Wild, Lu...
11/11/2025 14:03:01

JPMorgan downgrades CoreWeave, citing turbulence in AI infrastructure market. Despite near-term challenges, long-term growth...

Jasper Therapeutics Q3 EPS $(1.13) Beats $...
11/10/2025 13:05:26

Jasper Therapeutics (NASDAQ:JSPR) reported quarterly losses of $(1.13) per share which beat the analyst consensus estimate of $...

12 Health Care Stocks Moving In Wednesday'...
09/24/2025 21:06:04

Evercore ISI Group Maintains Outperform on...
09/22/2025 15:00:00

Evercore ISI Group analyst Gavin Clark-Gartner maintains Jasper Therapeutics (NASDAQ:JSPR) with a Outperform and lowers the ...

JMP Securities Maintains Market Outperform...
09/22/2025 13:22:25

JMP Securities analyst Silvan Tuerkcan maintains Jasper Therapeutics (NASDAQ:JSPR) with a Market Outperform and lowers the p...

BTIG Maintains Buy on Jasper Therapeutics,...
09/22/2025 09:36:45

BTIG analyst Justin Zelin maintains Jasper Therapeutics (NASDAQ:JSPR) with a Buy and lowers the price target from $20 to $7.

12 Health Care Stocks Moving In Friday's P...
09/19/2025 12:09:04

Jasper Therapeutics Announces $30M Public ...
09/19/2025 04:53:38

12 Health Care Stocks Moving In Thursday's...
09/18/2025 21:06:10

Jasper Therapeutics Announces Proposed Und...
09/18/2025 20:11:09

Jasper Therapeutics, Inc. (NASDAQ:JSPR) ("Jasper"), a clinical-stage biotechnology company focused on development of br...

UBS Maintains Buy on Jasper Therapeutics, ...
08/15/2025 14:21:43

UBS analyst Trung Huynh maintains Jasper Therapeutics (NASDAQ:JSPR) with a Buy and lowers the price target from $29 to $25.

Jasper Therapeutics Q2 EPS $(1.74) Misses ...
08/13/2025 20:26:46

Jasper Therapeutics (NASDAQ:JSPR) reported quarterly losses of $(1.74) per share which missed the analyst consensus estimate of...

Jasper Therapeutics Announces 50% Workforc...
07/09/2025 12:14:22

Reducing workforce by approximately 50% to focus on Chronic Urticaria programs and extend cash runwayDr. Edwin Tucker departing...

BMO Capital Downgrades Jasper Therapeutics...
07/08/2025 17:48:59

BMO Capital analyst Kostas Biliouris downgrades Jasper Therapeutics (NASDAQ:JSPR) from Outperform to Market Perform and lowe...

JMP Securities Maintains Market Outperform...
07/08/2025 14:11:14

JMP Securities analyst Silvan Tuerkcan maintains Jasper Therapeutics (NASDAQ:JSPR) with a Market Outperform and lowers the p...

Evercore ISI Group Maintains Outperform on...
07/08/2025 13:02:17

Evercore ISI Group analyst Gavin Clark-Gartner maintains Jasper Therapeutics (NASDAQ:JSPR) with a Outperform and lowers the ...

William Blair Downgrades Jasper Therapeuti...
07/07/2025 21:20:51

William Blair analyst Matt Phipps downgrades Jasper Therapeutics (NASDAQ:JSPR) from Outperform to Market Perform.

HC Wainwright & Co. Maintains Buy on Jaspe...
07/07/2025 20:47:40

HC Wainwright & Co. analyst Emily Bodnar maintains Jasper Therapeutics (NASDAQ:JSPR) with a Buy and lowers the price tar...

BTIG Maintains Buy on Jasper Therapeutics,...
07/07/2025 20:20:21

BTIG analyst Justin Zelin maintains Jasper Therapeutics (NASDAQ:JSPR) with a Buy and lowers the price target from $64 to $20.